Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $29,679,360 USD in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 196 grants at over 100 hospitals in 29 countries.
Texas Children's Cancer Center - $100,000
$100,000.00 USD
October 2012
Preclinical Evaluation of Novel BMI-1 Inhibitors In Vivo in Intra-Brainstem Orthotopic Xenograft Mouse Models
St. Jude's Children's Research Hospital - $15,000
$15,000.00 USD
October 2012
Establishment and Characterization of Renewable Tissue Resources for DIPG Research
DIPG Registry - $219,000
$219,000.00 USD
January 2012
Establishment of an International DIPG Registry
Texas Children's Cancer Center - $100,000
$100,000.00 USD
November 2011
Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001
Duke University - $82,049
$82,049.00 USD
November 2011
Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody
Doernbecher Children's Hospital - $100,000
$100,000.00 USD
November 2011
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
Sydney Children's Hospital - $100,000 USD / $100,420 AUD (Approx)
$100,000.00 USD
August 2011
Robotic screening for novel therapies for diffuse pontine gliomas
St. Jude's Children's Research Hospital - $35,000
$35,000.00 USD
September 2010
PI3K signaling effectors in DIPG
Cincinnati Children's Hospital - $35,000
$35,000.00 USD
September 2010
Establishment of a pre-clinical model for pediatric glioblastoma
Cincinnati Children's Hospital - $75,000
$75,000.00 USD
March 2010
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
Weill Cornell Medical College - $91,740
$91,740.00 USD
March 2010
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
St. Jude's Children's Research Hospital - $10,000
$10,000.00 USD
July 2009
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
July 2009
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
St. Jude's Children's Research Hospital - $50,000
$50,000.00 USD
July 2009
Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.
Cincinnati Children's Hospital - $50,000
$50,000.00 USD
September 2008
Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.